Ono Pharmaceutical has partnered with Phylo to integrate agentic AI tools into its drug discovery operations, making the technology available to its discovery scientists. The collaboration aims to enhance the efficiency and capabilities of Ono’s research teams by embedding AI agents throughout the discovery process.